sorry Rug but the evidence supporting the lack of fiscal ability of this board is staring us all in the face. Kudos for bringing the drug to phase 3 and much of that revolved around good science and the board has done well in this regard. But our journey financially has been a basket case. From PR making predictions that are way off the mark, to flipping from no CR to having CR several days later to suggesting that FDA approval will trigger the funding deals to Marco being let go, to SW leaving because he felt PR’s expectations regarding a deal was unreasonable, to Farmer Bob selling out for similar reasons, to PR paying himself an extraordinary salary and performance bonuses despite the dire position financially and very poor share price performance…I could go on. It stares us and PR in the face…..but we all hope the science wins thru….and we all know hope is a poor investment strategy.
PAR Price at posting:
29.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)